Plain-English translation of NCT07885397 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
China
Phase
Safety & dosing / Early efficacy
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators
BeiGene
Enrollment target
~60 participants
Started
October 2026
Primary completion
December 2027
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xianmin Song, MD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.